Negative News SentimentNegative News Bio-Rad Laboratories (BIO) Earnings Date, Estimates & Call Transcripts $307.00 +2.08 (+0.68%) (As of 12/1/2023 ET) Add Compare Share Share Today's Range$300.98▼$308.2750-Day Range$269.37▼$365.3452-Week Range$261.59▼$509.62Volume249,303 shsAverage Volume307,944 shsMarket Capitalization$8.95 billionP/E RatioN/ADividend YieldN/APrice Target$533.00 EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateFeb. 15EstimatedActual EPS (Oct. 26) $2.33 Missed By -$0.54 Consensus EPS (Oct. 26) $2.87 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Bio-Rad Laboratories Earnings AlertsEnter your email address below to receive the latest news and earnings results for BIO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBIO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BIO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Bio-Rad Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20232$3.23$3.23$3.23 Q2 20232$2.56$4.46$3.51 Q3 20232$2.87$3.47$3.17 Q4 20232$3.70$4.05$3.88 FY 20238$12.36$15.21$13.79 Q1 20241$3.28$3.28$3.28 Q2 20241$3.79$3.79$3.79 Q3 20241$3.75$3.75$3.75 Q4 20241$3.82$3.82$3.82 FY 20244$14.64$14.64$14.64 Q1 20251$5.34$5.34$5.34 Q2 20251$3.98$3.98$3.98 Q3 20251$4.56$4.56$4.56 BIO Earnings Date and InformationBio-Rad Laboratories last announced its quarterly earnings results on October 26th, 2023. The medical research company reported $2.33 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.87 by $0.54. The firm earned $632.10 million during the quarter, compared to the consensus estimate of $689.50 million. Its revenue was down 7.1% on a year-over-year basis. Bio-Rad Laboratories has generated ($5.85) earnings per share over the last year (($5.85) diluted earnings per share). Earnings for Bio-Rad Laboratories are expected to grow by 7.24% in the coming year, from $11.60 to $12.44 per share. Bio-Rad Laboratories has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 15th, 2024 based off prior year's report dates.Read More Bio-Rad Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 2/15/2024Estimated)------- 10/26/2023Q3 2023$2.87$2.33($0.54)$1.02$689.50 million$632.10 million 8/3/2023Q2 2023$2.55$3.00+$0.45$45.59$697.96 million$681.10 million 5/4/2023Q1 2023$3.24$3.34+$0.10$4.36$689.28 million$676.80 million 2/16/2023Q4 2022$3.45$3.31($0.14)($21.16)$741.01 million$730.29 million 10/27/2022Q3 2022$2.59$2.60+$0.01$10.72$685.50 million$680.10 million 7/28/2022Q2 2022$2.46$3.38+$0.92$37.88$664.60 million$691.10 million Get the Latest News and Ratings for BIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter. 4/28/2022Q1 2022$2.80$4.94+$2.14$122.45$678.00 million$700.10 million 2/10/2022Q4 2021$2.87$3.21+$0.34$59.01$731.94 million$732.80 million 10/28/2021Q3 2021$2.30$3.71+$1.41($122.54)$670.36 million$747.00 million 7/28/2021Q2 2021$2.66$3.54+$0.88($23.24)$610.40 million$715.93 million 4/29/2021Q1 2021$2.50$5.21+$2.71($21.96)$661.00 million$726.80 million 2/10/2021Q4 2020$3.30$4.01+$0.71($19.79)$681.80 million$789.84 million Bio-Rad Laboratories Earnings - Frequently Asked Questions When is Bio-Rad Laboratories's earnings date? Bio-Rad Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 15th, 2024 based off last year's report dates. Learn more on BIO's earnings history. Did Bio-Rad Laboratories beat their earnings estimates last quarter? In the previous quarter, Bio-Rad Laboratories (NYSE:BIO) missed the analysts' consensus estimate of $2.87 by $0.54 with a reported earnings per share (EPS) of $2.33. Learn more on analysts' earnings estimate vs. BIO's actual earnings. How can I listen to Bio-Rad Laboratories's earnings conference call? The conference call for Bio-Rad Laboratories's latest earnings report can be listened to online. Listen to Conference Call How can I read Bio-Rad Laboratories's conference call transcript? The conference call transcript for Bio-Rad Laboratories's latest earnings report can be read online. Read Transcript How can I view Bio-Rad Laboratories's earnings report? Bio-Rad Laboratories's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Bio-Rad Laboratories generate each year? Bio-Rad Laboratories (NYSE:BIO) has a recorded annual revenue of $2.80 billion. How much profit does Bio-Rad Laboratories generate each year? Bio-Rad Laboratories (NYSE:BIO) has a recorded net income of -$3.63 billion. BIO has generated -$5.85 earnings per share over the last four quarters. What is Bio-Rad Laboratories's EPS forecast for next year? Bio-Rad Laboratories's earnings are expected to grow from $11.60 per share to $12.44 per share in the next year, which is a 7.24% increase. More Earnings Resources from MarketBeat Related Companies: ILMN Earnings WAT Earnings BIO.B Earnings RVTY Earnings TXG Earnings AVTR Earnings OLK Earnings DVA Earnings PEN Earnings HSIC Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Earnings propel Crowdstrike, cybersecurity sector, to new highsAlibaba is down more than 10% since earnings, now what?2 stocks that faded their price gaps after crushing earnings Hims & Hers earnings highlight expanded personalized treatmentsCan Kohl's keep its momentum after earnings dip?Nvidia's earnings, dominance, growth and global challenges$20 looks like a good fit for The Gap after XL earnings beat This page (NYSE:BIO) was last updated on 12/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.